Recent investigations have also utilized a combination of antitumor drugs and regulators of the Nrf2-autophagy signaling axis to uncover the role of the Nrf2-autophagy signaling axis in the onset and progression of cancer. This evidence concerns the gene NFE2L2 and cancer.